Crossmark

Personalizing denosumab therapy in postmenopausal Indian women with osteoporosis: predictive role of bone turnover markers and body mass index in determining dosing interval

Crossref DOI link: https://doi.org/10.1007/s00198-025-07703-x

Published Online: 2025-09-29

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Jha, Vivek

Bhadada, Sanjay K. https://orcid.org/0000-0002-0410-8778
Pal, Rimesh

Kharbanda, Chirag

Rao, Sudhaker D.
License Information

Text and Data Mining valid from 2025-09-29

Version of Record valid from 2025-09-29
More Information

Article History

Received: 18 July 2025

Accepted: 12 September 2025

First Online: 29 September 2025

Declarations

:

: The study was approved by the institute’s ethics committee.

: Informed written consent was obtained from all the participants.

: None.

Document is current

Any future updates will be listed below